Stock Earnings

Question 1

What are Atara Biotherapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Atara Biotherapeutics Inc has a total asset of $109, Net loss of $-85

Question 2

What are the key financial ratios for ATRA?

Accepted Answer

Atara Biotherapeutics Inc's Current ratio is 0.52, has a Net margin is -66.4, sales per share of $17.09.

Question 3

How is Atara Biotherapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Atara Biotherapeutics Inc largest revenue segment is Therapeutics, at a revenue of 128,940,000 in the most earnings release.For geography, United States is the primary market for Atara Biotherapeutics Inc, at a revenue of 128,940,000.

Question 4

Is Atara Biotherapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Atara Biotherapeutics Inc has a net loss of $-85

Question 5

Does Atara Biotherapeutics Inc have any liabilities?

Accepted Answer

yes, Atara Biotherapeutics Inc has liability of 206

Question 6

How many outstanding shares for Atara Biotherapeutics Inc?

Accepted Answer

Atara Biotherapeutics Inc has a total outstanding shares of 5.85

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	151	128	8	63	20	0
Revenue Growth (YoY)	51%	1,500%	-87%	215%	--	--
Cost of Revenue	27	21	8	--	--	--
Gross Profit	124	107	0	--	--	--
Selling, General & Admin	29	38	49	68	78	64
Research & Development	52	147	219	269	282	244
Operating Expenses	82	186	268	338	360	309
Other Non Operating Income (Expenses)	0	0	0	--	--	--
Pretax Income	23	-85	-276	-228	-340	-306
Income Tax Expense	0	0	0	0	0	0
Net Income	23	-85	-276	-228	-340	-306
Net Income Growth	-117%	-69%	21%	-33%	11%	6%
Shares Outstanding (Diluted)	13.56	7.48	4.23	101.99	93.67	73.97
Shares Change (YoY)	82%	77%	-96%	9%	27%	44%
EPS (Diluted)	1.72	-11.4	-65.17	-2.24	-3.63	-4.15
EPS Growth	-110%	-83%	2,810%	-38%	-13%	-27%
Free Cash Flow	-69	-68	-194	-274	-231	-185
Free Cash Flow Per Share	-5.08	-9.08	-45.79	-2.68	-2.46	-2.5
Gross Margin	82.11%	83.59%	0%	--	--	--
Operating Margin	27.15%	-60.93%	-3,362.5%	-434.92%	-1,700%	0%
Profit Margin	15.23%	-66.4%	-3,450%	-361.9%	-1,700%	0%
Free Cash Flow Margin	-45.69%	-53.12%	-2,425%	-434.92%	-1,155%	0%
EBITDA	44	-73	-265	-269	-331	-301
EBITDA Margin	29.13%	-57.03%	-3,312.5%	-426.98%	-1,655%	0%
D&A For EBITDA	3	5	4	5	9	8
EBIT	41	-78	-269	-274	-340	-309
EBIT Margin	27.15%	-60.93%	-3,362.5%	-434.92%	-1,700%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Atara Biotherapeutics Inc (ATRA) Price

ATRA Stock Price Chart

ATRA Income

Follow-Up Questions